ABOUT US
TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases ...[More]
NEWS
-
TenNor Therapeutics Attended The 9th Chinese H. pylori and Digestive Diseases Forum
-
TenNor Held First Scientific Advisory Board Meeting
-
Lancet Oncology article reviews global burden of cancers caused by infections
-
Various aspects of Helicobacter pylori infection are summarized in a poster
-
Sounding the alarm, WHO publishes report on antimicrobial resistance
-
European experts publish consensus report on management of H. pylori infection
-
Global Antibiotic Pipeline
-
Human-Hp Mismatch Boosts Stomach Cancer
-
TenNor Acquires Patent from TB Alliance
-
TenNor was invited to speak at 5th China Healthcare Investment Conference